|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 655 15th Street, NW |
Address2 | Suite 500 |
City | Washington |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 1262-12
|
||||||||
|
6. House ID# 305260000
|
TYPE OF REPORT | 8. Year | 2023 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Annetha Hall |
Date | 1/22/2024 4:00:25 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
NAPA Reauthorization Act (S. 133/H.R. 619)
Alzheimers Accountability and Investment Act (S. 134/H.R. 620)
Comprehensive Care for Alzheimers Act (S. 626/H.R. 1637)
Elizabeth Dole Home Care Act of 2023 (S. 141/H.R. 542)
VA Clinician Appreciation, Recruitment, Education, Expansion, and Retention Support (CAREERS) Act of 2023 (S. 10)
Mandating Exclusive Review of Individual Treatments (MERIT) Act (H.R. 133)
Access to Innovative Treatments Act of 2023 (H.R. 2408)
Elder Justice Reauthorization and Modernization Act of 2023 (H.R. 2718/S. 1198)
Expanding Veterans Options for Long Term Care Act (H.R.1815/S. 495)
Palliative Care and Hospice Education and Training Act of 2023 (S.2243)
Facilitating Innovative Nuclear Diagnostics Act of 2023 (H.R. 1199/S. 1544)
Supporting Our Seniors Act (S. 2584)
Alleviating Barriers for Caregiving Act (S. 3109)
Reauthorization of the BOLD Infrastructure for Alzheimer's Act (P.L. 115-406)
Other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimers Disease
Other matters related to care payment models, including the GUIDE model
Other matters related to Medicare care planning code 99483
Other matters related to health care workforce shortages
Other matters related to home- and community-based services
Other matters related to disaster preparedness and older adults
Other matters related to Social Security
Other matters related to technology-enabled collaborative learning and capacity-building models (Project ECHO)
Other matters related to beta amyloid PET scans
Other matters related to selected diagnoses and services rendered under ICD-10
Other matters related to caregiving
Other matters related to medical devices
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Veterans Affairs - Dept of (VA), Centers For Disease Control & Prevention (CDC), Natl Institutes of Health (NIH), Federal Emergency Management Agency (FEMA), Social Security Administration (SSA), Government Accountability Office (GAO), Health Resources & Services Administration (HRSA), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Conant |
|
|
|
Sarah |
Tellock |
|
|
|
Jennifer |
Pollack |
|
|
|
Laura |
Thornhill |
|
|
|
Amy |
Heath |
|
|
|
Evan |
Holler |
|
|
|
Mary |
Germiller |
|
|
|
Sarah |
Osuna |
|
Legislative Assistant, Democratic Caucus Chair Pete Aguilar (2023), Legislative Aid, Rep. Aguilar (2023), Legislative Correspondent, Rep. Aguilar (2022), Staff Assistant, Rep. Aguilar (2020-2022) |
|
Zoe |
Salzberg |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Matters related to Fiscal Year 2024 appropriations for Alzheimers funding at the National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, Health Resources and Services Administration, Administration for Community Living, Department of Defense and Indian Health Service.
Appropriations related to OAA Title III-C Nutrition Program, and appropriations related to [88 FR 80085] Initiative on Women's Health Research.
Other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimers Disease.
Other matters related to beta amyloid PET scans.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Conant |
|
|
|
Sarah |
Tellock |
|
|
|
Laura |
Thornhill |
|
|
|
Jennifer |
Pollack |
|
|
|
Evan |
Holler |
|
|
|
Mary |
Germiller |
|
|
|
Sarah |
Osuna |
|
Legislative Assistant, Democratic Caucus Chair Pete Aguilar (2023), Legislative Aid, Rep. Aguilar (2023), Legislative Correspondent, Rep. Aguilar (2022), Staff Assistant, Rep. Aguilar (2020-2022) |
|
Zoe |
Salzberg |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |